Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies

Size: px
Start display at page:

Download "Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies"

Transcription

1 Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies Stanford Biostatistics Workshop Pierre Neuvial with Henrik Bengtsson and Terry Speed Department of Statistics, UC Berkeley September 30, 2010 Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

2 Outline Genotyping microarrays in cancer research 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

3 Outline Genotyping microarrays in cancer research DNA copy number changes in cancer cells 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

4 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genomic changes at the DNA level are hallmarks of cancer We inherited 23 paternal and 23 maternal chromosomes, mostly identical. Normal karyotype Tumor karyotype Our goal: identify CN changes to improve characterization, classification, and treatment of cancers Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

5 Genotyping microarrays in cancer research Genotypes in a diploid chromosome DNA copy number changes in cancer cells Genotypes in a diploid chromosome Single nucleotide polymorphism G C C T C A G G million known SNPs Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

6 Genotyping microarrays in cancer research Genotypes in a diploid chromosome DNA copy number changes in cancer cells Genotypes in a diploid chromosome Single nucleotide polymorphism A B B B AB BB B A AB A A AA million known SNPs Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

7 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotypes and copy numbers in a tumor Genotypes and copy numbers in a tumor Tumor with deletion copy-neutral LOH Matched Normal (diploid) Tumor with gain (0,2) - - BB BB BB BB A B B B AB BB A B BB BB ABB BBB (1,2) (0,1) (1,1) - A A A A AA B A AB A A AA A A B A AB AA (1,1) Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

8 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Parental, minor and major copy numbers Parental copy numbers at genomic locus j: (m j, p j ), the unobserved number of maternal and paternal chromosomes at j. Copy number state at genomic locus j CN = (C 1j, C 2j ), where C 1j = min(m j, p j ) and C 2j = max(m j, p j ). Minor (C 1 ) and major (C 2 ) copy numbers: characterize the above CN events in cancers can be estimated from SNP arrays Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

9 Outline Genotyping microarrays in cancer research Genotyping microarray data 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

10 Genotyping microarrays in cancer research Genotyping microarray data Technology: Technology: Copy number and genotyping microarrays Copy number and genotyping microarrays Chip Design Probes DNA T/C CGTGTAATTGAACC GCACATTAACTTGG GCACATCAACTTGG CGTGTAGTTGAACC CCCCGTAAAGTACT TATGCCGCCCTGCG ATACGGCGGGACGC Sample DNA + Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

11 Genotyping microarrays in cancer research Genotyping microarray data (C 1, C 2 ) can be estimated from SNP arrays For SNP j in sample i, observed signal intensities can be summarized as (θ, β), where θ ij = θ Aij + θ ijb and β ij = θ ijb /θ ij. Total copy numbers C ij = 2 θ ij θ Rj = C 1ij + C 2ij Decrease in heterozygosity DH ij = 2 β ij 1/2 = C 2ij C 1ij C 2ij + C 1ij Notes: DH only defined for SNPs that were heterozygous in the germline Both dimensions are needed to understand what is going on: Copy neutral LOH: CN = (0, 2), normal total copy number Balanced duplication: CN = (2, 2), allelic balance Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

12 Genotyping microarrays in cancer research Genotyping microarray data The Cancer Genome Atlas (TCGA) Accelerate our understanding of the molecular basis of cancer 20 tumor types: brain (glioblastoma multiforme), ovarian, breast, lung, leukemia (AML)... Large studies: 500 tumor-normal pairs for each tumor type Data levels: DNA copy number, gene expression, DNA methylation Platforms: microarray and sequencing For SNP arrays: identify copy number changes: (C, DH) or (C 1, C 2 ): 1 detection: finding regions 2 classification labeling regions Data shown in this presentation: high-grade serous ovarian adenocarcinoma (OvCa). Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

13 Outline Genotyping microarrays in cancer research Genotyping microarray data 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

14 Genotyping microarrays in cancer research No copy number change: (1,1) Genotyping microarray data BB AB AA Homozygous SNPs in the normal sample are highlighted in red. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

15 Gain: (1, 2) Genotyping microarrays in cancer research Genotyping microarray data BB AB AA Homozygous SNPs in the normal sample are highlighted in red. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

16 Deletion: (0, 1) Genotyping microarrays in cancer research Genotyping microarray data BB AB AA Homozygous SNPs in the normal sample are highlighted in red. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

17 Genotyping microarrays in cancer research Copy number neutral LOH: (0, 2) Genotyping microarray data BB AB AA Homozygous SNPs in the normal sample are highlighted in red. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

18 Genotyping microarrays in cancer research Tumor purity/normal contamination Genotyping microarray data In practice what we call tumor samples are actually a mixture of tumor and normal cells. The ones just shown have the largest fraction of tumor cells in the data set. In presence of normal contamination allele B fractions for heterozygous SNPs are shrunk toward 1/2. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

19 Genotyping microarrays in cancer research Normal, gain, copy neutral LOH Genotyping microarray data BB AB AA Homozygous SNPs in the normal sample are highlighted in red. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

20 Genotyping microarrays in cancer research Normal, deletion, copy neutral LOH Genotyping microarray data BB AB AA Homozygous SNPs in the normal sample are highlighted in red. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

21 Outline TumorBoost: improved power to detect CN changes 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

22 Outline TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

23 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Raw genomic signals: allelic ratios are noisy After preprocessing using the CRMAv2 method βt βn C Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

24 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects SNP effect in a region of no CN change in the tumor Instead of three points at (0,0), ( 1 2, 1 2 ) and (1,1), we have three clusters; the observed deviation is a SNP effect: δ ij = β ij µ ij δ is quite reproducible between the normal and the tumor Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

25 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects SNP effect in a region where tumor has a gain Homozygous clusters are similar as before Heterozygous cluster is split in two, and tilted Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

26 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects SNP effect in a region where tumor is CNNLOH Homozygous clusters are similar as before Heterozygous cluster is even more tilted Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

27 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Overview of the TumorBoost method Idea 1 the SNP effect is reproducible between tumor and normal 2 in the normal the truth is easier to infer because we only expect three true allele B fractions, corresponding to genotypes AA, AB, BB. For each SNP, we estimate the SNP effect in the normal hybridization, and subtract it from the tumor. Features No need to know copy number regions in advance Normalization is performed for each SNP separately Only one tumor/normal pair required H. Bengtsson, P. Neuvial, T.P. Speed TumorBoost: Normalization of allele-specific tumor copy numbers from a single pair of tumor-normal genotyping microarrays. BMC Bioinformatics (2010) 11:245. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

28 TumorBoost: improved power to detect CN changes Proposed normalization strategy Method: taking advantage of SNP effects Estimate the SNP effect in the normal sample as ˆδ Nj = β Nj ˆµ Nj, where ˆµ Nj {0, 1/2, 1} is the normal genotype For homozygous SNPs (ˆµ Nj {0, 1}): β Tj = β Tj β Nj + ˆµ Nj For heterozygous SNPs (ˆµ Nj 1/2): β Tj = { 1 2 βtj β Nj β Tj 1 β Nj if β Tj < β Nj otherwise Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

29 Outline TumorBoost: improved power to detect CN changes Results: improved signal to noise ratio 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

30 TumorBoost: improved power to detect CN changes Genomic signals before normalization Results: improved signal to noise ratio Normal, gain, copy neutral LOH Normal, loss, copy neutral LOH βn βt C Chromosome 2 (in Mb) Chromosome 10 (in Mb) Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

31 TumorBoost: improved power to detect CN changes Genomic signals after normalization Results: improved signal to noise ratio Normal, gain, copy neutral LOH Normal, loss, copy neutral LOH βn βt C Chromosome 2 (in Mb) Chromosome 10 (in Mb) Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

32 TumorBoost: improved power to detect CN changes Allele B fractions before normalization Results: improved signal to noise ratio Chromosome 10 Chromosome 2 Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

33 TumorBoost: improved power to detect CN changes Allele B fractions after normalization Results: improved signal to noise ratio Chromosome 10 Chromosome 2 Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

34 TumorBoost: improved power to detect CN changes ASCNs before normalization Results: improved signal to noise ratio Chromosome 10 Chromosome 2 Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

35 TumorBoost: improved power to detect CN changes ASCNs after normalization Results: improved signal to noise ratio Chromosome 10 Chromosome 2 Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

36 Outline TumorBoost: improved power to detect CN changes ROC evaluation 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

37 TumorBoost: improved power to detect CN changes ROC evaluation Detecting changes in allele B fractions allele B fractions: β allele B fractions for heterozygous SNPs mirrored allele B fractions for heterozygous SNPs: ρ = β 1/2 = DH/2 For heterozygous SNPs DH only has one mode so it can be segmented. We use ROC analysis to assess how separated two regions on each side of a known change point in DH are. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

38 TumorBoost: improved power to detect CN changes ROC evaluation ROC evaluation Available from aroma.cn.eval at: For a given sample: find a clear change point label flanking regions, e.g. NORMAL (1,1) and DELETION (0,1) choose one reference state and one state to call For each value of a threshold τ: Call SNPs below τ a DELETION Count number of true and false DELETIONs. ROC curve is built by adjusting τ. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

39 TumorBoost: improved power to detect CN changes ROC evaluation ROC evaluation Available from aroma.cn.eval at: For a given sample: find a clear change point label flanking regions, e.g. NORMAL (1,1) and DELETION (0,1) choose one reference state and one state to call For each value of a threshold τ: Call SNPs below τ a DELETION Count number of true and false DELETIONs. ROC curve is built by adjusting τ. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

40 TumorBoost: improved power to detect CN changes ROC evaluation ROC evaluation Available from aroma.cn.eval at: For a given sample: find a clear change point label flanking regions, e.g. NORMAL (1,1) and DELETION (0,1) choose one reference state and one state to call For each value of a threshold τ: Call SNPs below τ a DELETION Count number of true and false DELETIONs. ROC curve is built by adjusting τ. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

41 TumorBoost: improved power to detect CN changes ROC evaluation Result: Result: Better detection of allelic imbalances Better detection of allelic imbalances Allelic imbalance NORMAL REGION GAIN 100% TumorBoost Total CNs NORMAL REGION GAIN True-Positive Rate 50% Total CN original 0% False-Positive Rate 50% Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

42 TumorBoost: improved power to detect CN changes ROC evaluation Complete preprocessing for a single tumor/normal pair Available from aroma.cn and aroma.affymetrix at: Normalization and locus-level summarization using CRMAv2 (Bengtsson et al, 2009) for the normal and the tumor sample separately Naive genotyping of the normal sample: threshold density of β TumorBoost normalization (Bengtsson et al, 2010) Note: genotyping errors can be taken care of by smoothing or using confidence scores. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

43 TumorBoost: improved power to detect CN changes ROC evaluation Observed power to detect changes (1,1) vs (1,2) (1,1) vs (0,1) Legend: Total copy number Raw allele B fractions Normalized β (naive) Normalized β (Birdseed) (1,2) vs (0,2) (0,1) vs (0,2) TCN is consistent across change points β is not! Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

44 TumorBoost: improved power to detect CN changes ROC evaluation Expected power to detect changes C varies from one unit in all change points just shown For DH and thus (C 1, C 2 )) it s more complicated: ρ (0,2) (0,1) (1,3) (1,2) (1,1) (0,0) Tumor purity Difference in ρ (1,1) to (0,1) (1,2) to (0,2) (1,1) to (1,2) (0,1) to (0,2) Tumor purity The expected improvement depends on the type of change point and on normal contamination. Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

45 TumorBoost: improved power to detect CN changes ROC evaluation What if no matched normal is available? CalMaTe For each SNP: Estimate a calibration function (from observed signals to genotypes) using a set of reference samples Back-transform test samples Before CalMate normalization After CalMate normalization Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

46 Challenges for detecting and calling of copy number events Outline 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

47 Challenges for detecting and calling of copy number events Outline Detecting copy number changes from both C and DH 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

48 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Changes can be reflected in both dimensions Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

49 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH DH has greater detection power than C at a single locus Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

50 Challenges for detecting and calling of copy number events More informative probes for C than DH Affymetrix GenomeWideSNP 6 Detecting copy number changes from both C and DH All units CN units SNP units Frequency 1,856, , ,364 Proportion 100% 51% 49% Unit types All units AA AB BB Frequency 1,856, , , ,418 Proportion 100% 18% 14% 18% SNPs by genotype call for sample TCGA Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

51 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Similar detection power at a fixed resolution Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

52 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Need for a truly joint dimensional segmentation method Most methods segment only one of C and DH Some use two-way segmentation: Olshen et al, [PSCBS] A handful are truly two-dimensional : Chen et al, [pscn] Greenman et al, Biostat., 2010, [PICNIC] Sun et al, NAR, 2009, [genocna] Challenges for a truly joint segmentation method A two-dimensional signal Only heterozygous SNPs can be used to detect CN changes from DH Bias in the estimation of DH DH is not Gaussian Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

53 Challenges for detecting and calling of copy number events Outline Calling: influence of tumor purity, ploidy, and signal saturation 1 Genotyping microarrays in cancer research DNA copy number changes in cancer cells Genotyping microarray data 2 TumorBoost: improved power to detect CN changes Method: taking advantage of SNP effects Results: improved signal to noise ratio ROC evaluation 3 Challenges for detecting and calling of copy number events Detecting copy number changes from both C and DH Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

54 Challenges for detecting and calling of copy number events Copy numbers are not calibrated Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

55 ATION Challenges for detecting and calling of copy number events Non-calibrated signals: signal saturation Calling: influence of tumor purity, ploidy, and signal saturation CN obs = f(cn true ) < CN true C obs = f (C true ) < C obs f is unknown Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

56 Challenges for detecting and calling of copy number events Calling: influence of tumor purity, ploidy, and signal saturation Non-calibrated signals: ploidy and purity Copy number Pure tumor, ploidy = 2 Pure tumor, ploidy > Position (Mb) Copy number Position (Mb) Allele fractions Position (Mb) Allele fractions Position (Mb) Non pure tumor, ploidy=2 Non-pure tumor, ploidy < 2 Copy number Position (Mb) Copy number Position (Mb) Allele fractions Position (Mb) Allele fractions Position (Mb) Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

57 Challenges for detecting and calling of copy number events Calling: influence of tumor purity, ploidy, and signal saturation Purity, ploidy, and signal saturation Why copy numbers are not calibrated signal saturation non purity: presence of normal cells in the tumor sample ploidy: the total amount of DNA is fixed by the assay Remarks ploidy is not identifiable purity and ploidy are biological properties of the sample signal saturation is an artifact from the assay under the rug: tumor heterogeneity Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

58 Challenges for detecting and calling of copy number events Calling: influence of tumor purity, ploidy, and signal saturation OverUnder: Attiyeh et al, Genome Research, 2009 Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

59 Challenges for detecting and calling of copy number events Calling: influence of tumor purity, ploidy, and signal saturation GAP: Popova et al, Genome Biology, (a) BAF 0 1 (b) LRR X SNP Index B B allele frequency Pierre Neuvial (UC Berkeley) ~70% tumor cells (d) 0.0 Log R ratio Sub-clones A 0.0 BB AB -0.4 AA Log R ratio Log R ratio ABB AAB -0.4 (c) 0.4 Homozygous regions Germline -- Acquired B allele frequency SNP array data analyses in cancer studies p_baf = 0.3 q_lrr = (e) B allele frequency / 60

60 Challenges for detecting and calling of copy number events ASCAT: Van Loo et al, PNAS, 2010 Calling: influence of tumor purity, ploidy, and signal saturation Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

61 Challenges for detecting and calling of copy number events Calling: influence of tumor purity, ploidy, and signal saturation Comments on existing approaches What about Affymetrix data? Choice between candidate solutions Perform ad hoc correction for saturation Tumor heterogeneity? Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

62 Challenges for detecting and calling of copy number events Calling: influence of tumor purity, ploidy, and signal saturation Thanks Henrik Bengtsson Adam Olshen Maria Ortiz Angel Rubio Venkat E. Seshan Terry Speed Paul Spellman Nancy R. Zhang Funding: The Cancer Genome Atlas Pierre Neuvial (UC Berkeley) SNP array data analyses in cancer studies / 60

Understanding DNA Copy Number Data

Understanding DNA Copy Number Data Understanding DNA Copy Number Data Adam B. Olshen Department of Epidemiology and Biostatistics Helen Diller Family Comprehensive Cancer Center University of California, San Francisco http://cc.ucsf.edu/people/olshena_adam.php

More information

Genome-wide copy-number calling (CNAs not CNVs!) Dr Geoff Macintyre

Genome-wide copy-number calling (CNAs not CNVs!) Dr Geoff Macintyre Genome-wide copy-number calling (CNAs not CNVs!) Dr Geoff Macintyre Structural variation (SVs) Copy-number variations C Deletion A B C Balanced rearrangements A B A B C B A C Duplication Inversion Causes

More information

Comparison of segmentation methods in cancer samples

Comparison of segmentation methods in cancer samples fig/logolille2. Comparison of segmentation methods in cancer samples Morgane Pierre-Jean, Guillem Rigaill, Pierre Neuvial Laboratoire Statistique et Génome Université d Évry Val d Éssonne UMR CNRS 8071

More information

DNA-seq Bioinformatics Analysis: Copy Number Variation

DNA-seq Bioinformatics Analysis: Copy Number Variation DNA-seq Bioinformatics Analysis: Copy Number Variation Elodie Girard elodie.girard@curie.fr U900 institut Curie, INSERM, Mines ParisTech, PSL Research University Paris, France NGS Applications 5C HiC DNA-seq

More information

Introduction to LOH and Allele Specific Copy Number User Forum

Introduction to LOH and Allele Specific Copy Number User Forum Introduction to LOH and Allele Specific Copy Number User Forum Jonathan Gerstenhaber Introduction to LOH and ASCN User Forum Contents 1. Loss of heterozygosity Analysis procedure Types of baselines 2.

More information

ADVANCED PGT SERVICES

ADVANCED PGT SERVICES Genomic Prediction ADVANCED PGT SERVICES with PGT-A using SEQ is a cost-effective, rigorously validated, unambiguous, and streamlined test for aneuploidy in blastocyst biopsies, and uses state of the art

More information

Global variation in copy number in the human genome

Global variation in copy number in the human genome Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)

More information

The Loss of Heterozygosity (LOH) Algorithm in Genotyping Console 2.0

The Loss of Heterozygosity (LOH) Algorithm in Genotyping Console 2.0 The Loss of Heterozygosity (LOH) Algorithm in Genotyping Console 2.0 Introduction Loss of erozygosity (LOH) represents the loss of allelic differences. The SNP markers on the SNP Array 6.0 can be used

More information

Biostatistical modelling in genomics for clinical cancer studies

Biostatistical modelling in genomics for clinical cancer studies This work was supported by Entente Cordiale Cancer Research Bursaries Biostatistical modelling in genomics for clinical cancer studies Philippe Broët JE 2492 Faculté de Médecine Paris-Sud In collaboration

More information

Human Cancer Genome Project. Bioinformatics/Genomics of Cancer:

Human Cancer Genome Project. Bioinformatics/Genomics of Cancer: Bioinformatics/Genomics of Cancer: Professor of Computer Science, Mathematics and Cell Biology Courant Institute, NYU School of Medicine, Tata Institute of Fundamental Research, and Mt. Sinai School of

More information

BACOM2: a Java tool for detecting normal cell contamination of copy number in heterogeneous tumor

BACOM2: a Java tool for detecting normal cell contamination of copy number in heterogeneous tumor Page 1 BACOM2: a Java tool for detecting normal cell contamination of copy number in heterogeneous tumor Yi Fu 1, Jun Ruan 2, Guoqiang Yu 1, Douglas A. Levine 3, Niya Wang 1, Ie- Ming Shih 4, Zhen Zhang

More information

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer Supplementary Information Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer Lars A. Forsberg, Chiara Rasi, Niklas Malmqvist, Hanna Davies, Saichand

More information

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014

Challenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014 Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical

More information

DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK

DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK CHAPTER 6 DOES THE BRCAX GENE EXIST? FUTURE OUTLOOK Genetic research aimed at the identification of new breast cancer susceptibility genes is at an interesting crossroad. On the one hand, the existence

More information

Clinical Genomics. Ina E. Amarillo, PhD FACMGG

Clinical Genomics. Ina E. Amarillo, PhD FACMGG Clinical Genomics Ina E. Amarillo, PhD FACMGG Associate Medical Director, Cytogenetics Lab (CaTG), Lab and Genomic Medicine Assistant Professor, Pathology and Immunology Outline Clinical Genomics Testing

More information

UTILIZATION OF A SNP MICROARRAY FOR CHRONIC LYMPHOCYTIC LEUKEMIA: EFFICACY, INFORMATIVE FINDINGS AND PROGNOSTIC CAPABILITIES

UTILIZATION OF A SNP MICROARRAY FOR CHRONIC LYMPHOCYTIC LEUKEMIA: EFFICACY, INFORMATIVE FINDINGS AND PROGNOSTIC CAPABILITIES UTILIZATION OF A SNP MICROARRAY FOR CHRONIC LYMPHOCYTIC LEUKEMIA: EFFICACY, INFORMATIVE FINDINGS AND PROGNOSTIC CAPABILITIES S Schwartz, Z Hosseini, S Schepis, P Papenhausen Laboratory Corporation of America

More information

LTA Analysis of HapMap Genotype Data

LTA Analysis of HapMap Genotype Data LTA Analysis of HapMap Genotype Data Introduction. This supplement to Global variation in copy number in the human genome, by Redon et al., describes the details of the LTA analysis used to screen HapMap

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/7/283/283ra54/dc1 Supplementary Materials for Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

More information

The role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia

The role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia The role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia Adrian Zordan, Meaghan Wall, Ruth MacKinnon, Pina D Achille & Lynda Campbell Victorian Cancer Cytogenetics Service (VCCS)

More information

Absolute quantification of somatic DNA alterations in human cancer

Absolute quantification of somatic DNA alterations in human cancer Absolute quantification of somatic DNA alterations in human cancer The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation

More information

Chapter 1 : Genetics 101

Chapter 1 : Genetics 101 Chapter 1 : Genetics 101 Understanding the underlying concepts of human genetics and the role of genes, behavior, and the environment will be important to appropriately collecting and applying genetic

More information

Identification of regions with common copy-number variations using SNP array

Identification of regions with common copy-number variations using SNP array Identification of regions with common copy-number variations using SNP array Agus Salim Epidemiology and Public Health National University of Singapore Copy Number Variation (CNV) Copy number alteration

More information

Introduction to Gene Sets Analysis

Introduction to Gene Sets Analysis Introduction to Svitlana Tyekucheva Dana-Farber Cancer Institute May 15, 2012 Introduction Various measurements: gene expression, copy number variation, methylation status, mutation profile, etc. Main

More information

On Missing Data and Genotyping Errors in Association Studies

On Missing Data and Genotyping Errors in Association Studies On Missing Data and Genotyping Errors in Association Studies Department of Biostatistics Johns Hopkins Bloomberg School of Public Health May 16, 2008 Specific Aims of our R01 1 Develop and evaluate new

More information

Gene expression analysis. Roadmap. Microarray technology: how it work Applications: what can we do with it Preprocessing: Classification Clustering

Gene expression analysis. Roadmap. Microarray technology: how it work Applications: what can we do with it Preprocessing: Classification Clustering Gene expression analysis Roadmap Microarray technology: how it work Applications: what can we do with it Preprocessing: Image processing Data normalization Classification Clustering Biclustering 1 Gene

More information

OncoPhase: Quantification of somatic mutation cellular prevalence using phase information

OncoPhase: Quantification of somatic mutation cellular prevalence using phase information OncoPhase: Quantification of somatic mutation cellular prevalence using phase information Donatien Chedom-Fotso 1, 2, 3, Ahmed Ashour Ahmed 1, 2, and Christopher Yau 3, 4 1 Ovarian Cancer Cell Laboratory,

More information

Computational Analysis of Genome-Wide DNA Copy Number Changes

Computational Analysis of Genome-Wide DNA Copy Number Changes Computational Analysis of Genome-Wide DNA Copy Number Changes Lei Song Thesis submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015

Computer Science, Biology, and Biomedical Informatics (CoSBBI) Outline. Molecular Biology of Cancer AND. Goals/Expectations. David Boone 7/1/2015 Goals/Expectations Computer Science, Biology, and Biomedical (CoSBBI) We want to excite you about the world of computer science, biology, and biomedical informatics. Experience what it is like to be a

More information

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray

Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray Assessment of Breast Cancer with Borderline HER2 Status Using MIP Microarray Hui Chen, Aysegul A Sahin, Xinyan Lu, Lei Huo, Rajesh R Singh, Ronald Abraham, Shumaila Virani, Bal Mukund Mishra, Russell Broaddus,

More information

Statistics 202: Data Mining. c Jonathan Taylor. Final review Based in part on slides from textbook, slides of Susan Holmes.

Statistics 202: Data Mining. c Jonathan Taylor. Final review Based in part on slides from textbook, slides of Susan Holmes. Final review Based in part on slides from textbook, slides of Susan Holmes December 5, 2012 1 / 1 Final review Overview Before Midterm General goals of data mining. Datatypes. Preprocessing & dimension

More information

Clinical Interpretation of Cancer Genomes

Clinical Interpretation of Cancer Genomes IGENZ Ltd, Auckland, New Zealand Clinical Interpretation of Cancer Genomes Dr Amanda Dixon-McIver www.igenz.co.nz 1992 Slovenia and Croatia gain independence USA and Russia declare the Cold War over Steffi

More information

CS2220 Introduction to Computational Biology

CS2220 Introduction to Computational Biology CS2220 Introduction to Computational Biology WEEK 8: GENOME-WIDE ASSOCIATION STUDIES (GWAS) 1 Dr. Mengling FENG Institute for Infocomm Research Massachusetts Institute of Technology mfeng@mit.edu PLANS

More information

Structural Variation and Medical Genomics

Structural Variation and Medical Genomics Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,

More information

Research Strategy: 1. Background and Significance

Research Strategy: 1. Background and Significance Research Strategy: 1. Background and Significance 1.1. Heterogeneity is a common feature of cancer. A better understanding of this heterogeneity may present therapeutic opportunities: Intratumor heterogeneity

More information

The laws of Heredity. Allele: is the copy (or a version) of the gene that control the same characteristics.

The laws of Heredity. Allele: is the copy (or a version) of the gene that control the same characteristics. The laws of Heredity 1. Definition: Heredity: The passing of traits from parents to their offspring by means of the genes from the parents. Gene: Part or portion of a chromosome that carries genetic information

More information

Application of Whole Genome Microarrays in Cancer: You should be doing this test!!

Application of Whole Genome Microarrays in Cancer: You should be doing this test!! Application of Whole Genome Microarrays in Cancer: You should be doing this test!! Daynna Wolff, Ph.D. Director, Cytogenetics and Genomics Disclosures Clinical Laboratory Director and Employee, Medical

More information

Supplementary note: Comparison of deletion variants identified in this study and four earlier studies

Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Here we compare the results of this study to potentially overlapping results from four earlier studies

More information

SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization

SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization Qiao et al. Genome Biology 2014, 15:443 METHOD Open Access SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization Yi Qiao

More information

CHROMOSOMAL MICROARRAY (CGH+SNP)

CHROMOSOMAL MICROARRAY (CGH+SNP) Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due

More information

SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts

SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation carrier and normal blastocysts J Assist Reprod Genet (2016) 33:1115 1119 DOI 10.1007/s10815-016-0734-0 TECHNOLOGICAL INNOVATIONS SNP array-based analyses of unbalanced embryos as a reference to distinguish between balanced translocation

More information

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit

Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter

More information

A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data

A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data Li and Li Genome Biology 2014, 15:473 METHOD A general framework for analyzing tumor subclonality using SNP array and DNA sequencing data Bo Li 1 and Jun Z Li 2 Open Access Abstract Intra-tumor heterogeneity

More information

Contents. 1.5 GOPredict is robust to changes in study sets... 5

Contents. 1.5 GOPredict is robust to changes in study sets... 5 Supplementary documentation for Data integration to prioritize drugs using genomics and curated data Riku Louhimo, Marko Laakso, Denis Belitskin, Juha Klefström, Rainer Lehtonen and Sampsa Hautaniemi Faculty

More information

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott

Seven cases of intellectual disability analysed by genomewide SNP analysis. Rodney J. Scott Seven cases of intellectual disability analysed by genomewide SNP analysis Rodney J. Scott Ability to interrogate Genomic Material ~1930 Crude analyses 2012 Highly precise analyses A (very) brief history

More information

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016

Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics

More information

Computational Systems Biology: Biology X

Computational Systems Biology: Biology X Bud Mishra Room 1002, 715 Broadway, Courant Institute, NYU, New York, USA L#4:(October-0-4-2010) Cancer and Signals 1 2 1 2 Evidence in Favor Somatic mutations, Aneuploidy, Copy-number changes and LOH

More information

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University

Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic

More information

Analysis of CGH and SNP arrays for the detection of chromosomal aberrations in single cells

Analysis of CGH and SNP arrays for the detection of chromosomal aberrations in single cells Analysis of CGH and SNP arrays for the detection of chromosomal aberrations in single cells Peter Konings 1 Evelyne Vanneste 1,2 Thierry Voet 1 Cédric Le Caignec 1 Michèle Ampe 1 Cindy Melotte 1 Sophie

More information

Nature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from

Nature Genetics: doi: /ng Supplementary Figure 1. SEER data for male and female cancer incidence from Supplementary Figure 1 SEER data for male and female cancer incidence from 1975 2013. (a,b) Incidence rates of oral cavity and pharynx cancer (a) and leukemia (b) are plotted, grouped by males (blue),

More information

Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification

Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification Using CART to Mine SELDI ProteinChip Data for Biomarkers and Disease Stratification Kenna Mawk, D.V.M. Informatics Product Manager Ciphergen Biosystems, Inc. Outline Introduction to ProteinChip Technology

More information

Copy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics

Copy Number Variations and Association Mapping Advanced Topics in Computa8onal Genomics Copy Number Variations and Association Mapping 02-715 Advanced Topics in Computa8onal Genomics SNP and CNV Genotyping SNP genotyping assumes two copy numbers at each locus (i.e., no CNVs) CNV genotyping

More information

Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Complete Genomics, Inc.

Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Complete Genomics, Inc. Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Topics Overview of Data Processing Pipeline Overview of Data Files 2 DNA Nano-Ball (DNB) Read Structure Genome : acgtacatgcattcacacatgcttagctatctctcgccag

More information

Advances In Measurement Modeling: Bringing Genetic Information Into Preventive Interventions And Getting The Phenotype Right

Advances In Measurement Modeling: Bringing Genetic Information Into Preventive Interventions And Getting The Phenotype Right Advances In Measurement Modeling: Bringing Genetic Information Into Preventive Interventions And Getting The Phenotype Right Bengt Muthen, UCLA bmuthen@ucla.edu 1 Modeling The Influence On A Person s Behavior

More information

Copy number and somatic mutations drive tumors

Copy number and somatic mutations drive tumors Detection of copy number alterations, ploidy and loss of heterozygosity across the genome in FFPE specimens Utility for diagnosis and treatment with comparison to FISH-based and as a complement to sequencing

More information

Supplementary Material to. Genome-wide association study identifies new HLA Class II haplotypes strongly protective against narcolepsy

Supplementary Material to. Genome-wide association study identifies new HLA Class II haplotypes strongly protective against narcolepsy Supplementary Material to Genome-wide association study identifies new HLA Class II haplotypes strongly protective against narcolepsy Hyun Hor, 1,2, Zoltán Kutalik, 3,4, Yves Dauvilliers, 2,5 Armand Valsesia,

More information

CNV Detection and Interpretation in Genomic Data

CNV Detection and Interpretation in Genomic Data CNV Detection and Interpretation in Genomic Data Benjamin W. Darbro, M.D., Ph.D. Assistant Professor of Pediatrics Director of the Shivanand R. Patil Cytogenetics and Molecular Laboratory Overview What

More information

The Biology and Genetics of Cells and Organisms The Biology of Cancer

The Biology and Genetics of Cells and Organisms The Biology of Cancer The Biology and Genetics of Cells and Organisms The Biology of Cancer Mendel and Genetics How many distinct genes are present in the genomes of mammals? - 21,000 for human. - Genetic information is carried

More information

Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy

Genomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy Genomic complexity and arrays in CLL Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy Clinical relevance of genomic complexity (GC) in CLL GC has been identified as a critical negative

More information

CHAPTER 2. Cancer Res Nov 15; 65(22):

CHAPTER 2. Cancer Res Nov 15; 65(22): RELIABLE HIGH-THROUPHGPUT GENOTYPING AND LOSS OF HETEROZYGOSITY DETECTION IN FORMALIN- FIXED, PARAFFIN-EMBEDDED TUMORS USING SINGLE NUCLEOTIDE POLYMORPHISM ARRAYS CHAPTER 2 Reliable high-throughput genotyping

More information

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi

CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi 2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000

More information

Ploidy and large-scale genomic instability consistently identify basal-like breast

Ploidy and large-scale genomic instability consistently identify basal-like breast Supplementary Data and Figures Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation Popova T, Manié E, Rieunier G, Caux-Moncoutier V,

More information

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017

Large-scale identity-by-descent mapping discovers rare haplotypes of large effect. Suyash Shringarpure 23andMe, Inc. ASHG 2017 Large-scale identity-by-descent mapping discovers rare haplotypes of large effect Suyash Shringarpure 23andMe, Inc. ASHG 2017 1 Why care about rare variants of large effect? Months from randomization 2

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,

More information

Genetics and Diversity Punnett Squares

Genetics and Diversity Punnett Squares Genetics and Diversity Punnett Squares 1 OUTCOME QUESTION(S): S1-1-12: How are the features of the parents inherited to create unique offspring? Vocabulary & Concepts Allele Dominant Recessive Genotype

More information

What can we contribute to cancer research and treatment from Computer Science or Mathematics? How do we adapt our expertise for them

What can we contribute to cancer research and treatment from Computer Science or Mathematics? How do we adapt our expertise for them From Bioinformatics to Health Information Technology Outline What can we contribute to cancer research and treatment from Computer Science or Mathematics? How do we adapt our expertise for them Introduction

More information

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC

Molecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Molecular Markers Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Testing methods Rationale for molecular testing

More information

UNIT 3 GENETICS LESSON #30: TRAITS, GENES, & ALLELES. Many things come in many forms. Give me an example of something that comes in many forms.

UNIT 3 GENETICS LESSON #30: TRAITS, GENES, & ALLELES. Many things come in many forms. Give me an example of something that comes in many forms. UNIT 3 GENETICS LESSON #30: TRAITS, GENES, & ALLELES Many things come in many forms. Give me an example of something that comes in many forms. Genes, too, come in many forms. Main Idea #1 The same gene

More information

Tutorial on Genome-Wide Association Studies

Tutorial on Genome-Wide Association Studies Tutorial on Genome-Wide Association Studies Assistant Professor Institute for Computational Biology Department of Epidemiology and Biostatistics Case Western Reserve University Acknowledgements Dana Crawford

More information

Hematopathology Service Memorial Sloan Kettering Cancer Center, New York

Hematopathology Service Memorial Sloan Kettering Cancer Center, New York SH2017-0334 t(14;18) Negative Follicular Lymphoma with 1p36 abnormality associated with In Situ Follicular Neoplasia with t(14;18) translocation Pallavi Khattar MD, Jennifer Maerki MD, Alexander Chan MD,

More information

Nature Medicine: doi: /nm.3967

Nature Medicine: doi: /nm.3967 Supplementary Figure 1. Network clustering. (a) Clustering performance as a function of inflation factor. The grey curve shows the median weighted Silhouette widths for varying inflation factors (f [1.6,

More information

Systematic Analysis for Identification of Genes Impacting Cancers

Systematic Analysis for Identification of Genes Impacting Cancers Systematic Analysis for Identification of Genes Impacting Cancers Arpita Singhal Stanford University Saint Francis High School ABSTRACT Currently, vast amounts of molecular information involving genomic

More information

November 9, Johns Hopkins School of Medicine, Baltimore, MD,

November 9, Johns Hopkins School of Medicine, Baltimore, MD, Fast detection of de-novo copy number variants from case-parent SNP arrays identifies a deletion on chromosome 7p14.1 associated with non-syndromic isolated cleft lip/palate Samuel G. Younkin 1, Robert

More information

Analysis of Somatic Alterations in Cancer Genome: From SNP Arrays to Next Generation Sequencing

Analysis of Somatic Alterations in Cancer Genome: From SNP Arrays to Next Generation Sequencing Analysis of Somatic Alterations in Cancer Genome: From SNP Arrays to Next Generation Sequencing Tatiana Popova, Valentina Boeva, Elodie Manié, Yves Rozenholc, Emmanuel Barillot, Marc-Henri Stern To cite

More information

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns

Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه

More information

Genomic structural variation

Genomic structural variation Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural

More information

Introduction to genetic variation. He Zhang Bioinformatics Core Facility 6/22/2016

Introduction to genetic variation. He Zhang Bioinformatics Core Facility 6/22/2016 Introduction to genetic variation He Zhang Bioinformatics Core Facility 6/22/2016 Outline Basic concepts of genetic variation Genetic variation in human populations Variation and genetic disorders Databases

More information

Dan Koller, Ph.D. Medical and Molecular Genetics

Dan Koller, Ph.D. Medical and Molecular Genetics Design of Genetic Studies Dan Koller, Ph.D. Research Assistant Professor Medical and Molecular Genetics Genetics and Medicine Over the past decade, advances from genetics have permeated medicine Identification

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 28

More information

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis

The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis The 16th KJC Bioinformatics Symposium Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis Tieliu Shi tlshi@bio.ecnu.edu.cn The Center for bioinformatics

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC.

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC. Supplementary Figure 1 Rates of different mutation types in CRC. (a) Stratification by mutation type indicates that C>T mutations occur at a significantly greater rate than other types. (b) As for the

More information

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2 For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?

More information

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays

Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Addressing the challenges of genomic characterization of hematologic malignancies using microarrays Sarah South, PhD, FACMG Medical Director, ARUP Laboratories Department of Pediatrics and Pathology University

More information

Aspects of Statistical Modelling & Data Analysis in Gene Expression Genomics. Mike West Duke University

Aspects of Statistical Modelling & Data Analysis in Gene Expression Genomics. Mike West Duke University Aspects of Statistical Modelling & Data Analysis in Gene Expression Genomics Mike West Duke University Papers, software, many links: www.isds.duke.edu/~mw ABS04 web site: Lecture slides, stats notes, papers,

More information

By Mir Mohammed Abbas II PCMB 'A' CHAPTER CONCEPT NOTES

By Mir Mohammed Abbas II PCMB 'A' CHAPTER CONCEPT NOTES Chapter Notes- Genetics By Mir Mohammed Abbas II PCMB 'A' 1 CHAPTER CONCEPT NOTES Relationship between genes and chromosome of diploid organism and the terms used to describe them Know the terms Terms

More information

Lab Activity 36. Principles of Heredity. Portland Community College BI 233

Lab Activity 36. Principles of Heredity. Portland Community College BI 233 Lab Activity 36 Principles of Heredity Portland Community College BI 233 Terminology of Chromosomes Homologous chromosomes: A pair, of which you get one from mom, and one from dad. Example: the pair of

More information

Unit 5: Genetics Notes

Unit 5: Genetics Notes Unit 5: Genetics Notes https://goo.gl/fgtzef Name: Period: Test Date: Table of Contents Title of Page Page Number Date Warm-ups 3-4 Mendelian Genetics Notes 5-6 Mendelian Genetics Lets Practice 7 Monohybrid

More information

White Paper. Copy number variant detection. Sample to Insight. August 19, 2015

White Paper. Copy number variant detection. Sample to Insight. August 19, 2015 White Paper Copy number variant detection August 19, 2015 Sample to Insight CLC bio, a QIAGEN Company Silkeborgvej 2 Prismet 8000 Aarhus C Denmark Telephone: +45 70 22 32 44 Fax: +45 86 20 12 22 www.clcbio.com

More information

GENOME-WIDE ASSOCIATION STUDIES

GENOME-WIDE ASSOCIATION STUDIES GENOME-WIDE ASSOCIATION STUDIES SUCCESSES AND PITFALLS IBT 2012 Human Genetics & Molecular Medicine Zané Lombard IDENTIFYING DISEASE GENES??? Nature, 15 Feb 2001 Science, 16 Feb 2001 IDENTIFYING DISEASE

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20

More information

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.

SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,

More information

BST227 Introduction to Statistical Genetics. Lecture 4: Introduction to linkage and association analysis

BST227 Introduction to Statistical Genetics. Lecture 4: Introduction to linkage and association analysis BST227 Introduction to Statistical Genetics Lecture 4: Introduction to linkage and association analysis 1 Housekeeping Homework #1 due today Homework #2 posted (due Monday) Lab at 5:30PM today (FXB G13)

More information

Distinguishing Second Primary Cancers From Metastases: Statistical Challenges in Testing Clonal Relatedness of Tumors

Distinguishing Second Primary Cancers From Metastases: Statistical Challenges in Testing Clonal Relatedness of Tumors Distinguishing Second Primary Cancers From Metastases: Statistical Challenges in Testing Clonal Relatedness of Tumors Colin Begg Department of Epidemiology and Biostatistics Memorial Sloan-Kettering Cancer

More information

Compound heterozygosity Yurii S. Aulchenko yurii [dot] aulchenko [at] gmail [dot] com. Thursday, April 11, 13

Compound heterozygosity Yurii S. Aulchenko yurii [dot] aulchenko [at] gmail [dot] com. Thursday, April 11, 13 Compound heterozygosity Yurii S. Aulchenko yurii [dot] aulchenko [at] gmail [dot] com 1 Outline Recessive model Examples of Compound Heterozygosity Compound Double Heterozygosity (CDH) test 2 Recessive

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Mutational signatures in BCC compared to melanoma.

Nature Genetics: doi: /ng Supplementary Figure 1. Mutational signatures in BCC compared to melanoma. Supplementary Figure 1 Mutational signatures in BCC compared to melanoma. (a) The effect of transcription-coupled repair as a function of gene expression in BCC. Tumor type specific gene expression levels

More information

Non-Mendelian inheritance

Non-Mendelian inheritance Non-Mendelian inheritance Focus on Human Disorders Peter K. Rogan, Ph.D. Laboratory of Human Molecular Genetics Children s Mercy Hospital Schools of Medicine & Computer Science and Engineering University

More information

Cytogenetics Technologies, Companies & Markets

Cytogenetics Technologies, Companies & Markets Cytogenetics Technologies, Companies & Markets By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland November 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R A P H Y Professor

More information

Antigen Presentation to T lymphocytes

Antigen Presentation to T lymphocytes Antigen Presentation to T lymphocytes Immunology 441 Lectures 6 & 7 Chapter 6 October 10 & 12, 2016 Jessica Hamerman jhamerman@benaroyaresearch.org Office hours by arrangement Antigen processing: How are

More information

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data Breast cancer Inferring Transcriptional Module from Breast Cancer Profile Data Breast Cancer and Targeted Therapy Microarray Profile Data Inferring Transcriptional Module Methods CSC 177 Data Warehousing

More information

Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data

Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data Quantification of Normal Cell Fraction and Copy Number Neutral LOH in Clinical Lung Cancer Samples Using SNP Array Data Hanna Göransson 1, Karolina Edlund 2, Maria Rydåker 1, Markus Rasmussen 1, Johan

More information